05:53 PM EDT, 05/05/2026 (MT Newswires) -- TransMedics Group ( TMDX ) reported Q1 adjusted net income late Tuesday of $0.30 per diluted share, down from $0.74 a year earlier.

Analysts polled by FactSet expected $0.60.

Revenue in the three months ended March 31 rose to $173.9 million from $143.5 million a year earlier.

Analysts surveyed by FactSet expected $174.5 million.

The company reiterated its 2026 revenue guidance of $727 million to $757 million. Analysts expect $740.2 million.

TransMedics ( TMDX ) shares fell more than 17% in after-hours trading.